Lucid Diagnostics Inc. financial data

Symbol
LUCD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Madison Avenue, 25 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -43.1%
Debt-to-equity 351 % +341%
Return On Equity -664 % -164%
Return On Assets -147 % -5.17%
Operating Margin -1.17K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.2M shares +21.8%
Common Stock, Shares, Outstanding 49.3M shares +17.9%
Entity Public Float 14.4M USD -23.8%
Common Stock, Value, Issued 49K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 48.2M shares +15.2%
Weighted Average Number of Shares Outstanding, Diluted 48.2M shares +15.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.8M USD +514%
Revenue from Contract with Customer, Excluding Assessed Tax 3.8M USD +514%
Cost of Revenue 369K USD
Research and Development Expense 6.41M USD -26%
Selling and Marketing Expense 16.6M USD -2.65%
General and Administrative Expense 17.5M USD -21.1%
Operating Income (Loss) -44.6M USD +19.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46.7M USD +18%
Net Income (Loss) Attributable to Parent -46.7M USD +18%
Earnings Per Share, Basic -1.22 USD/shares +16.4%
Earnings Per Share, Diluted -1.22 USD/shares +14.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.9M USD -23.5%
Accounts Receivable, after Allowance for Credit Loss, Current 160K USD +357%
Inventory, Net 683K USD
Assets, Current 27.9M USD -21.8%
Property, Plant and Equipment, Net 1.05M USD -24.4%
Operating Lease, Right-of-Use Asset 3.04M USD +65.5%
Intangible Assets, Net (Excluding Goodwill) 947K USD -61.1%
Other Assets, Noncurrent 1.13M USD +5.01%
Assets 34.1M USD -19.7%
Accounts Payable, Current 903K USD +41.8%
Employee-related Liabilities, Current 1.18M USD +34%
Liabilities, Current 16M USD -40.1%
Operating Lease, Liability, Noncurrent 2.15M USD +194%
Liabilities 18.1M USD -33.9%
Retained Earnings (Accumulated Deficit) -180M USD -43.1%
Stockholders' Equity Attributable to Parent 16M USD +6.03%
Liabilities and Equity 34.1M USD -19.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD -77.1%
Net Cash Provided by (Used in) Financing Activities 18.5M USD -23.4%
Net Cash Provided by (Used in) Investing Activities -37K USD -118%
Common Stock, Shares Authorized 300M shares +50%
Common Stock, Shares, Issued 49.3M shares +17.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.87M USD -65.6%
Deferred Tax Assets, Valuation Allowance 42.2M USD +62.2%
Deferred Tax Assets, Gross 42.2M USD +62.2%
Operating Lease, Liability 3.04M USD +65.9%
Depreciation 24K USD +700%
Payments to Acquire Property, Plant, and Equipment 17K USD -88.5%
Lessee, Operating Lease, Liability, to be Paid 3.44M USD +75.9%
Property, Plant and Equipment, Gross 2.1M USD +11.7%
Operating Lease, Liability, Current 884K USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 952K USD +650%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD -10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 406K USD +220%
Lessee, Operating Lease, Liability, to be Paid, Year Three 913K USD +1349%
Deferred Tax Assets, Operating Loss Carryforwards 29.1M USD +81.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1K USD -95.8%
Operating Lease, Payments 305K USD +7.02%
Additional Paid in Capital 140M USD +10%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.49M USD -79.2%
Depreciation, Depletion and Amortization 501K USD -18.1%
Deferred Tax Assets, Net of Valuation Allowance 42.2M USD +62.2%
Share-based Payment Arrangement, Expense 4.35M USD -63.5%
Interest Expense 178K USD -97.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%